Company Information
- Type:
- Company
- Country:
- Chile
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 23 March 2012 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Engagements
Forward Faster
Communication On Progress
Published On | Title | Level/Status |
---|---|---|
25-Jul-2024 | 2024 Communication on Progress | Submitted |
11-Dec-2023 | 2023 Communication on Progress | Submitted |
14-Nov-2022 | Informe de Sostenibilidad 2021 | Active |
16-Nov-2021 | Informe de Sostenibilidad 2020 | Active |
16-Dec-2020 | Reporte de Sostenibilidad 2019 | Active |
12-Oct-2019 | Communication on Progress | Active |
17-Aug-2018 | Reporte de Sostenibilidad 2017 | Active |
09-Jun-2017 | Communication on Progress | Active |
05-May-2016 | Communication on Progress | Active |
05-May-2015 | Communication on Progress 2013 - 2014 | Active |
05-May-2014 | Communication on Progress 2013 | Active |
06-May-2013 | Comunicación de progreso Laboratorio Bagó 2011 | Active |
02-May-2013 | Comunicación de progreso Laboratorio Bagó | Active |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.